Popular weight-loss drugs shouldn't carry suicide warnings, FDA …
1 day ago · Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their blockbuster weight-loss drugs. The U.S.
FDA Requests Removal of Suicidal Behavior and Ideation Warning …
2 days ago · FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications
FDA calls on GLP-1 drugmakers to remove suicide warnings
The Food and Drug Administration on Tuesday told Eli Lilly and Novo Nordisk to remove warnings about the risk of suicidal thoughts and behavior from the labels of their blockbuster GLP-1 …
Drugmakers welcome FDA’s GLP-1RA suicide warning removal …
8 hours ago · The US Food and Drug Administration (FDA) has requested that pharma companies marketing glucagon-like peptide-1 receptor agonists (GLP-1RAs) no longer include warnings …
FDA Requests Removal of Suicide Warning on GLP-1s - Medscape
8 hours ago · The FDA requested that manufacturers of GLP-1 receptor agonists (RAs) remove the warning regarding the risk of suicidal ideation and behavior (SI/B) from the drugs’ labeling. …
FDA Issues Removal of Suicidal Behavior and Ideation Warning From GLP-1 ...
2 days ago · FDA removes suicidal ideation warnings from GLP-1 RA medications, highlighting their potential benefits in weight loss and mental health treatment.
FDA Says to Drop Suicide Warning From GLP-1 Drug Labels
1 day ago · The FDA requested that manufacturers of GLP-1 receptor agonists remove information regarding risks of suicidal behavior and ideation from drug labels following a …
US FDA requests removal of suicide warnings from weight-loss drug …
1 day ago · The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo …
FDA moves to strike suicide risk warnings from 3 GLP-1s
10 hours ago · The FDA is requesting that drugmakers remove suicidal ideation and behavior warnings from the labeling of three GLP-1 receptor agonists — Saxenda (liraglutide), Wegovy …
FDA asks for removal of suicidal ideation risk from GLP-1 ... - Healio
9 hours ago · The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation and behavior from their labels following an …